Screener
Teladoc Health TDOC Ratios & Valuation
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 69%-1.3pp | 69.3%-1.2pp | 69.5%-1.3pp | 69.8%-1.0pp | 70.3%-0.5pp | |
| Operating margin | -7.5%+3.0pp | -8.1%+33.2pp | -10.4%+29.3pp | -10.9%+28.0pp | -10.5%+28.9pp | |
| Net margin | -7.1%+1.0pp | -6.8%+32.9pp | -7.9%+31.0pp | -8.8%+29.1pp | -8.2%+30.4pp | |
| Returns | ||||||
| Return on equity | -13%+1.2pp | -12.4%+42.1pp | -13.9%+38.5pp | -15.4%+36.2pp | -14.2%+38.8pp | |
| Return on invested capital | -15.9%+15.2pp | -28%+73.8pp | -36.6%+63.4pp | -34.9%+57.9pp | -31.1%+57.4pp | |
| Efficiency | ||||||
| Asset turnover | 0.9×+0.1× | 0.8×+0.1× | 0.8×+0.1× | 0.8×+0.1× | 0.8×+0.1× | |
| Liquidity | ||||||
| Current ratio | 0.8×-1.8× | 2.8×+1.1× | 2.8×+1.0× | 2.7×+1.0× | 2.7×+1.0× | |
| Leverage | ||||||
| Debt-to-equity | 0.8×+0.8× | 0×-0.4× | 0×-0.4× | 0×-0.4× | 0×-0.4× | |
| Net debt / EBITDA | 1.5×+9.6× | -4.7×— | -8.4×— | -9.7×— | -8.1×— | |
| Per Share | ||||||
| Book value per share | $7.24-10.5% | $7.46-9.0% | $7.86-10.1% | $7.87-10.5% | $8.08-8.4% | |
| Valuation | ||||||
| Market capitalization | $1.21B-1.7% | $972.26M-29.7% | $1.24B-20.6% | $1.37B-12.6% | $1.4B-14.4% | |
| Price / sales | 0.5×0.0× | 0.4×-0.2× | 0.5×-0.1× | 0.5×-0.1× | 0.6×-0.1× | |
| Price / book | 0.9×+0.1× | 0.7×-0.2× | 0.9×-0.2× | 1×-0.1× | 1×-0.1× | |
| EV / EBITDA | 8.7×+1.1× | 1.7×— | 5.8×— | 9.8×— | 9.7×— |
FAQ
- What are Teladoc Health's profit margins?
- Teladoc Health (TDOC) runs a 69.0% gross margin and a -7.5% operating margin, with a -7.1% net margin.
- Where do Teladoc Health's ratios come from?
- Every ratio is computed from Teladoc Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
